TAL - Spark Newswire

3 minute read

Earnings

Earnings Scheduled For January 19, 2023

January 19, 6:23 AM

Companies Reporting Before The Bell • Procter & Gamble (NYSE:PG) is estimated to report quarterly earnings at $1.59 per share on revenue of $20.73 billion.

AMTB

1 minute read

TAL Education Q3 Adj EPS $(0.04) Misses $0.02 Estimate, Sales $232.70M Miss $239.83M Estimate

By Benzinga Newsdesk

January 19, 5:07 AM

TAL Education (NYSE:TAL) reported adjusted quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $0.02 by 300 percent. This is a 55.56 percent increase over losses of $(0.09) per share from

TAL

1 minute read

News

Why TAL Education Shares Are Trading Lower Today

By Henry Khederian

January 17, 3:36 PM

TAL Education Group (NYSE: TAL) shares are trading lower by 4.75% to $8.23 Tuesday.

TAL

2 minute read

Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday

By Lisa Levin

January 9, 11:36 AM

U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.

AGL

1 minute read

Here’s Why Gaotu Techedu And TAL Education Shares Are Moving

By Henry Khederian

January 4, 3:31 PM

Gaotu Techedu Inc (NYSE: GOTU) and TAL Education Group (NYSE: TAL) shares are trading higher Wednesday afternoon.

GOTU

1 minute read

Movers

12 Consumer Discretionary Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

December 29, 9:08 AM

Gainers Elys Game Technology (NASDAQ:ELYS) shares increased by 34.5% to $0.35 during Thursday’s pre-market session. The market value…

CZOO

1 minute read

Gaotu Techedu, TAL Education And Other Chinese Edtech Shares Plunge As China Heightens Crackdown

By Anusuya Lahiri

December 29, 7:57 AM

China looked further to tighten supervision over its battered online education sector.

BEDU

4 minute read

Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

December 28, 2:00 PM

Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.

$APE